Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network.

Moreau P, Sonneveld P, Boccadoro M, Cook G, Mateos MV, Nahi H, Goldschmidt H, Dimopoulos MA, Lucio P, Bladé J, Delforge M, Hajek R, Ludwig H, Facon T, Miguel JFS, Einsele H.

Haematologica. 2019 Dec;104(12):2358-2360. doi: 10.3324/haematol.2019.224204. Epub 2019 Aug 22.

2.

Multiple myeloma in elderly patients-a Portuguese multicentric real-life study.

João C, Bergantim R, Neves M, Chacim S, Afonso C, Barradas J, Bernardo M, Coelho H, Esteves G, Fraga C, Geraldes C, Gonçalves C, Jorge A, Macedo A, Mendonça T, Moreira A, Roque A, Sarmento AB, Trigo F, Vitória H, Esteves S, Lúcio P.

Ann Hematol. 2019 Jul;98(7):1689-1701. doi: 10.1007/s00277-019-03640-y. Epub 2019 Apr 8.

PMID:
30963200
3.

The trajectory of balance skill development from childhood to adolescence was influenced by birthweight: a latent transition analysis in a British birth cohort.

Okuda PMM, Swardfager W, Lucio PS, Ploubidis GB, Liu T, Pangelinan M, Cogo-Moreira H.

J Clin Epidemiol. 2019 May;109:12-19. doi: 10.1016/j.jclinepi.2018.12.012. Epub 2018 Dec 17.

PMID:
30572083
4.

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators.

N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12.

5.

Psychometric Investigation of the Raven's Colored Progressive Matrices Test in a Sample of Preschool Children.

Lúcio PS, Cogo-Moreira H, Puglisi M, Polanczyk GV, Little TD.

Assessment. 2019 Oct;26(7):1399-1408. doi: 10.1177/1073191117740205. Epub 2017 Nov 9.

PMID:
29121785
6.

Testing Measurement Invariance across Groups of Children with and without Attention-Deficit/ Hyperactivity Disorder: Applications for Word Recognition and Spelling Tasks.

Lúcio PS, Salum G, Swardfager W, Mari JJ, Pan PM, Bressan RA, Gadelha A, Rohde LA, Cogo-Moreira H.

Front Psychol. 2017 Oct 25;8:1891. doi: 10.3389/fpsyg.2017.01891. eCollection 2017.

7.

Comparability of an ADHD Latent Trait Between Groups: Disentangling True Between-Group Differences From Measurement Problems.

Cogo-Moreira H, Lúcio PS, Swardfager W, Gadelha A, Mari JJ, Miguel EC, Rohde LA, Salum GA.

J Atten Disord. 2019 May;23(7):712-720. doi: 10.1177/1087054717707047. Epub 2017 May 6.

PMID:
28478691
8.

Poor stimulus discriminability as a common neuropsychological deficit between ADHD and reading ability in young children: a moderated mediation model.

Lúcio PS, Salum GA, Rohde LA, Swardfager W, Gadelha A, Vandekerckhove J, Pan PM, Polanczyk GV, do Rosário MC, Jackowski AP, Mari JJ, Cogo-Moreira H.

Psychol Med. 2017 Jan;47(2):255-266. doi: 10.1017/S0033291716002531. Epub 2016 Oct 4.

PMID:
27697085
9.

Tumor-associated macrophages (TAMs): clinical-pathological parameters in squamous cell carcinomas of the lower lip.

Lúcio PS, Ribeiro DC, Aguiar MC, Alves PM, Nonaka CF, Godoy GP.

Braz Oral Res. 2016 Aug 22;30(1):e95. doi: 10.1590/1807-3107BOR-2016.vol30.0095.

10.

Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment.

João C, Freitas J, Gomes F, Geraldes C, Coelho I, Neves M, Lúcio P, Esteves S, Esteves GV.

Ann Hematol. 2016 May;95(6):931-6. doi: 10.1007/s00277-016-2662-6. Epub 2016 Apr 11.

PMID:
27068406
11.

Socio-economic and Climate Factors Associated with Dengue Fever Spatial Heterogeneity: A Worked Example in New Caledonia.

Teurlai M, Menkès CE, Cavarero V, Degallier N, Descloux E, Grangeon JP, Guillaumot L, Libourel T, Lucio PS, Mathieu-Daudé F, Mangeas M.

PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004211. doi: 10.1371/journal.pntd.0004211. eCollection 2015 Dec.

12.

Psychometric equivalence of the Brazilian version of the Test of Pragmatic Language 2 – TOPL-2.

Carvalho CA, Lúcio PS, Ávila CR.

Codas. 2015 Jul-Aug;27(4):344-9. doi: 10.1590/2317-1782/20152013032. English, Portuguese.

13.

[Monoclonal gammopathies of indetermined significance: diagnosis and clinical follow-up guidelines].

Parreira J, Lúcio P, João C, Macedo A, Sarmento AB, Geraldes C, Gonçalves C, Esteves G.

Acta Med Port. 2014 Sep-Oct;27(5):661-4. Epub 2014 Oct 31. Portuguese.

14.

Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance rounds.

Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira CE, van der Velden VH, Novakova M, Mejstrikova E, Hrusak O, Böttcher S, Karsch D, Sędek Ł, Trinquand A, Boeckx N, Caetano J, Asnafi V, Lucio P, Lima M, Helena Santos A, Bonaccorso P, van der Sluijs-Gelling AJ, Langerak AW, Martin-Ayuso M, Szczepański T, van Dongen JJ, Orfao A.

Cytometry A. 2015 Feb;87(2):145-56. doi: 10.1002/cyto.a.22581. Epub 2014 Oct 23.

15.

Efficacy and safety of lenalidomide in relapse/refractory multiple myeloma--real life experience of a tertiary cancer center.

João C, Coelho I, Costa C, Esteves S, Lucio P.

Ann Hematol. 2015 Jan;94(1):97-105. doi: 10.1007/s00277-014-2164-3. Epub 2014 Jul 20.

PMID:
25038919
16.

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor.

Martins LR, Perera Y, Lúcio P, Silva MG, Perea SE, Barata JT.

Oncotarget. 2014 Jan 15;5(1):258-63.

17.

Flight height preference for oviposition of mosquito (Diptera: Culicidae) vectors of sylvatic yellow fever virus near the hydroelectric reservoir of Simplício, Minas Gerais, Brazil.

Alencar J, Morone F, De Mello CF, Dégallier N, Lucio PS, de Serra-Freire NM, Guimarães AE.

J Med Entomol. 2013 Jul;50(4):791-5.

PMID:
23926776
18.

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.

Martins LR, Lúcio P, Melão A, Antunes I, Cardoso BA, Stansfield R, Bertilaccio MT, Ghia P, Drygin D, Silva MG, Barata JT.

Leukemia. 2014 Jan;28(1):179-82. doi: 10.1038/leu.2013.232. Epub 2013 Aug 8. No abstract available.

PMID:
23925046
19.

A case study of the influence of local weather on Aedes aegypti (L.) aging and mortality.

Lucio PS, Degallier N, Servain J, Hannart A, Durand B, de Souza RN, Ribeiro ZM.

J Vector Ecol. 2013 Jun;38(1):20-37. doi: 10.1111/j.1948-7134.2013.12005.x.

20.

Aggressive ameloblastic fibro-odontoma assessment with CBCT and treatment.

Lúcio PS, Cavalcante RB, Maia RN, Santos ES, Godoy GP.

Eur Arch Paediatr Dent. 2013 Jun;14(3):179-84. doi: 10.1007/s40368-013-0032-9. Epub 2013 Apr 30.

PMID:
23633233
21.

Myofibroblasts and their relationship with oral squamous cell carcinoma.

Lúcio PS, Cavalcanti AL, Alves PM, Godoy GP, Nonaka CF.

Braz J Otorhinolaryngol. 2013 Jan-Feb;79(1):112-8. Review. English, Portuguese.

22.

The influence of local environment on the aging and mortality of Aedes aegypti (L.): case study in Fortaleza-CE, Brazil.

Degallier N, Servain J, Lucio PS, Hannart A, Durand B, de Souza RN, Ribeiro ZM.

J Vector Ecol. 2012 Dec;37(2):428-41. doi: 10.1111/j.1948-7134.2012.00247.x.

23.

Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.

Dekking EH, van der Velden VH, Varro R, Wai H, Böttcher S, Kneba M, Sonneveld E, Koning A, Boeckx N, Van Poecke N, Lucio P, Mendonça A, Sedek L, Szczepański T, Kalina T, Kanderová V, Hoogeveen P, Flores-Montero J, Chillón MC, Orfao A, Almeida J, Evans P, Cullen M, Noordijk AL, Vermeulen PM, de Man MT, Dixon EP, Comans-Bitter WM, van Dongen JJ; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708).

Leukemia. 2012 Sep;26(9):1976-85. doi: 10.1038/leu.2012.125. Epub 2012 May 8.

24.

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

van Dongen JJ, Lhermitte L, Böttcher S, Almeida J, van der Velden VH, Flores-Montero J, Rawstron A, Asnafi V, Lécrevisse Q, Lucio P, Mejstrikova E, Szczepański T, Kalina T, de Tute R, Brüggemann M, Sedek L, Cullen M, Langerak AW, Mendonça A, Macintyre E, Martin-Ayuso M, Hrusak O, Vidriales MB, Orfao A; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708).

Leukemia. 2012 Sep;26(9):1908-75. doi: 10.1038/leu.2012.120. Epub 2012 May 3.

25.

On CK2 regulation of chronic lymphocytic leukemia cell viability.

Martins LR, Lúcio P, Silva MC, Gameiro P, Silva MG, Barata JT.

Mol Cell Biochem. 2011 Oct;356(1-2):51-5. doi: 10.1007/s11010-011-0947-6. Epub 2011 Jul 13.

PMID:
21750986
26.

[Economic analysis of rituximab in combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in Portugal].

Braga P, Carvalho S, Gomes M, Guerra L, Lúcio P, Marques H, Negreiro F, Pereira C, Silva C, Teixeira A.

Acta Med Port. 2010 Nov-Dec;23(6):1025-34. Epub 2010 Dec 28. Portuguese.

27.

Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay.

Dekking E, van der Velden VH, Böttcher S, Brüggemann M, Sonneveld E, Koning-Goedheer A, Boeckx N, Lucio P, Sedek L, Szczepański T, Kalina T, Kovac M, Evans P, Hoogeveen PG, Flores-Montero J, Orfao A, Comans-Bitter WM, Staal FJ, van Dongen JJ; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708).

Best Pract Res Clin Haematol. 2010 Sep;23(3):333-45. doi: 10.1016/j.beha.2010.09.010. Epub 2010 Nov 3. Review.

PMID:
21123134
28.

Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia.

Martins LR, Lúcio P, Silva MC, Anderes KL, Gameiro P, Silva MG, Barata JT.

Blood. 2010 Oct 14;116(15):2724-31. doi: 10.1182/blood-2010-04-277947. Epub 2010 Jul 21.

PMID:
20660292
29.

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.

Weerkamp F, Dekking E, Ng YY, van der Velden VH, Wai H, Böttcher S, Brüggemann M, van der Sluijs AJ, Koning A, Boeckx N, Van Poecke N, Lucio P, Mendonça A, Sedek L, Szczepański T, Kalina T, Kovac M, Hoogeveen PG, Flores-Montero J, Orfao A, Macintyre E, Lhermitte L, Chen R, Brouwer-De Cock KA, van der Linden A, Noordijk AL, Comans-Bitter WM, Staal FJ, van Dongen JJ; EuroFlow Consortium.

Leukemia. 2009 Jun;23(6):1106-17. doi: 10.1038/leu.2009.93. Epub 2009 Apr 23.

PMID:
19387467
30.

Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells.

Neves H, Weerkamp F, Gomes AC, Naber BA, Gameiro P, Becker JD, Lúcio P, Clode N, van Dongen JJ, Staal FJ, Parreira L.

Stem Cells. 2006 May;24(5):1328-37. Epub 2006 Jan 12.

31.

Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.

Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, Parreira A, Ramos F, Ruiz-Cabello F, Suarez-Vilela D, San Miguel JF, Orfao A.

Haematologica. 2004 Jan;89(1):58-69.

32.

A probability model for the meiosis I non-disjunction fraction in numerical chromosomal anomalies.

Franco GC, Lucio PS, Parra FC, Pena SD.

Stat Med. 2003 Jun 30;22(12):2015-24.

PMID:
12802819
33.

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

Vidriales MB, Pérez JJ, López-Berges MC, Gutiérrez N, Ciudad J, Lucio P, Vazquez L, García-Sanz R, del Cañizo MC, Fernández-Calvo J, Ramos F, Rodríguez MJ, Calmuntia MJ, Porwith A, Orfao A, San-Miguel JF.

Blood. 2003 Jun 15;101(12):4695-700. Epub 2003 Feb 13.

PMID:
12586618
34.

BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.

Lucio P, Gaipa G, van Lochem EG, van Wering ER, Porwit-MacDonald A, Faria T, Bjorklund E, Biondi A, van den Beemd MW, Baars E, Vidriales B, Parreira A, van Dongen JJ, San Miguel JF, Orfao A; BIOMED-I.

Leukemia. 2001 Aug;15(8):1185-92.

35.

BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).

Porwit-MacDonald A, Björklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, van den Beemd MW, van Wering ER, Baars E, Gaipa G, Biondi A, Ciudad J, van Dongen JJ, San Miguel JF, Orfao A.

Leukemia. 2000 May;14(5):816-25.

36.

Immunophenotypical detection of minimal residual disease in acute leukemia.

San Miguel JF, Ciudad J, Vidriales MB, Orfao A, Lucio P, Porwit-MacDonald A, Gaipa G, van Wering E, van Dongen JJ.

Crit Rev Oncol Hematol. 1999 Dec;32(3):175-85. Review. No abstract available.

PMID:
10633847
37.

CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma.

Lúcio P, Parreira A, Orfao A.

Ann Intern Med. 1999 Oct 5;131(7):549-50. No abstract available.

PMID:
10507983
38.

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

Orfao A, Schmitz G, Brando B, Ruiz-Arguelles A, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF.

Clin Chem. 1999 Oct;45(10):1708-17. Review.

39.

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.

Lúcio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, van Dongen JJ, San Miguel JF.

Leukemia. 1999 Mar;13(3):419-27.

40.

Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.

Lúcio PJ, Faria MT, Pinto AM, da Silva MR, Correia Júnior ME, da Costa RJ, Parreira AB.

Haematologica. 1998 Feb;83(2):104-11.

41.

Large-volume leukaphereses may be more efficient than standard-volume leukaphereses for collection of peripheral blood progenitor cells.

Passos-Coelho JL, Machado MA, Lúcio P, Leal-Da-Costa F, Silva MR, Parreira A.

J Hematother. 1997 Oct;6(5):465-74.

PMID:
9368183
42.

Haploidentical cord blood transplant contaminated with maternal T cells in a patient with advanced leukaemia.

Abecasis MM, Machado AM, Boavida G, Silva MG, Lúcio P, Ambrósio A, Jorge ML.

Bone Marrow Transplant. 1996 May;17(5):891-5.

PMID:
8733718

Supplemental Content

Support Center